Genetic differences between Asian and Caucasian chronic lymphocytic leukemia

International Journal of Oncology

Volumn 43, Issue 2, 2013, Pages 561-565

  Kawamata, Norihiko ^a   Moreilhon, Chimene ^b   Saitoh, Takayuki ^c   Karasawa, Masamitsu ^c   Bernstein, Brian K ^a   Sato Otsubo, Aiko ^d   Ogawa, Seishi ^d   Raynaud, Sophie ^a   Koeffler, H Phillip ^a,e  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c GUNMA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Caspase; Common genomic changes; IRF4; SNP chip

Indexed keywords

CASPASE 4; CASPASE 5; CD19 ANTIGEN; CD20 ANTIGEN; CD5 ANTIGEN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1BETA CONVERTING ENZYME;

ARTICLE; ASIAN; CAUCASIAN; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHRONIC LYMPHATIC LEUKEMIA; ETHNICITY; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRISOMY 12; TRISOMY 18;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOME ABERRATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC MARKERS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; SEQUENCE DELETION; TRISOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 84879671027     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1966     Document Type: Article

References (40)

1. DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA and Weinberg RA: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 8th edition. Lippncott Williams & Wilkins, 2009.
2. Eley JW, Hill HA, Chen VW, et al: Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272: 947-954, 1994. (Pubitemid 24288549)
3. GLOBOCAN 2008/Cancer Incidence and Mortality Worldwide in 2008. International Agency for Research on Cancer. World Health Organization. http://globocan.iarc.fr/
4. Tsugane S and Sasazuki S: Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10: 75-83, 2007. (Pubitemid 46955941)
5. Dunn JE: Cancer epidemiology in populations of the United States - with emphasis on Hawaii and California - and Japan. Cancer Res 35: 3240-3245, 1975.
6. Jänne PA, Engelman JA and Johnson BE: Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol 23: 3227-3234, 2005.
7. Bell DW, Lynch TJ, Haserlat SM, et al: Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol 23: 8081-8092, 2005. (Pubitemid 46657411)
8. Rai KR and Keating MJ: Chronic Lymphocytic Leukemia. Chapter 127. Cancer Medicine. 6th edition. BC Decker, Hamilton, ON, 2000.
9. Redaelli A, Laskin BL, Stephens JM, Botteman MF and Pashos CL: The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care 13: 279-287, 2004. (Pubitemid 38834460)
10. SEER Stat Fact Sheets: Chronic Lymphocytic Leukemia. Surveillance epidemiology and end of results. National Cancer Institute. http://seer.cancer. gov/statfacts/html/clyl.html
11. Gale RP, Cozen W, Goodman MT, Wang FF and Bernstein L: Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County. Leuk Res 24: 665-669, 2000. (Pubitemid 30495500)
12. Pan JW, Cook LS, Schwartz SM and Weis NS: Incidence of leukemia in Asian migrants to the United States and their descendants. Cancer Causes Control 13: 791-795, 2002. (Pubitemid 35305197)
13. Hallek M, Cheson BD, Catovsky D, et al: Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111: 5446-5456, 2008.
14. Nakahashi H, Tsukamoto N, Hashimoto Y, et al: Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders. Cancer Sci 100: 671-677, 2009.
15. Kawamata N, Ogawa S, Gueller S, et al : Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array. Exp Hematol 37: 937-946, 2009.
16. Yamamoto G, Nannya Y, Kato M, et al: Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet 81: 114-126, 2007. (Pubitemid 47001161)
17. Lehmann S, Ogawa S, Raynaud SD, et al: Molecular allelokaryo-typing of early-stage, untreated chronic lymphocytic leukemia. Cancer 112: 1296-1305, 2008. (Pubitemid 351429745)
18. Caporaso N, Goldin L, Plass C, et al: Chronic lymphocytic leukaemia genetics overview. Br J Haematol 139: 630-634, 2007. (Pubitemid 350123477)
19. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al: A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 40: 1204-1210, 2008.
20. Kitada S, Andersen J, Akar S, et al: Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91: 3379-3389, 1998. (Pubitemid 28193890)
21. Majid A, Tsoulakis O, Walewska R, et al: BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism. Blood 111: 874-877, 1998.
22. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002. (Pubitemid 35403967)
23. Calin GA, Ferracin M, Cimmino A, et al: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005. (Pubitemid 41549891)
24. Calin GA and Croce CM: Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood 114: 4761-4770, 2009.
25. Cimmino A, Calin GA, Fabbri M, et al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949, 2006.
26. Abramson JS and Shipp MA: Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 106: 1164-1174, 2005. (Pubitemid 41129574)
27. Basso K and Dalla-Favera R: BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv Immunol 105: 193-210, 2010.
28. Phan RT and Dalla-Favera R: The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432: 635-639, 2004. (Pubitemid 39626271)
29. Ching YP, Wong CM, Chan SF, et al: Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem 278: 10824-10830, 2003.
30. Lahoz A and Hall A: DLC1: a significant GAP in the cancer genome. Genes Dev 22: 1724-1730, 2008. (Pubitemid 351915495)
31. Yin XL, Pang JC and Ng HK: Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma. Oncogene 21: 1461-1468, 2002. (Pubitemid 34214510)
32. Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC and Reynolds SH: DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23: 1405-1411, 2004. (Pubitemid 38406835)
33. Zender L, Xue W, Zuber J, et al: An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135: 852-864, 2008.
34. Rinaldi A, Mian M, Chigrinova E, et al: Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 117: 1595-1604, 2011.
35. Tagawa H, Suguro M, Tsuzuki S, et al: Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 106: 1770-1777, 2005. (Pubitemid 41208593)
36. Swerdlow SH, Campo E, Harris NL, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. World Health Organization, 2008.
37. Martinon F and Tschopp J: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10-22, 2007. (Pubitemid 44911890)
38. Davis BK, Wen H and Ting JP: The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707-735, 2011.
39. Altshuler D, Daly MJ and Lander ES: Genetic mapping in human disease. Science 322: 881-888, 2008.
40. Clifford RJ, Edmonson MN, Nguyen C, Scherpbier T, Hu Y and Buetow KH: Bioinformatics tools for single nucleotide polymorphism discovery and analysis. Ann NY Acad Sci 1020: 101-109, 2004. (Pubitemid 38736928)